Efficacy and Safety of Combination Therapy Consisting of Angiotensin II Type 1 Receptor Blocker, Calcium Channel Blocker and Hydrochlorothiazide in Patients With Hypertension.

Journal of clinical medicine research（2017）

引用 1|浏览14

暂无评分

摘要

Combination therapy with H-ARB/CCB/HCTZ was associated with a significant reduction of BP.

查看译文

关键词

Angiotensin II type 1 receptor blocker,Blood pressure,Calcium channel blocker,Hydrochlorothiazide

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要